Actively Recruiting
Temple Health Chest Initiative (THCI 2.0)
Led by Temple University · Updated on 2025-04-18
1000
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT screening for lung cancer in patients aged 50- 80 with ≥ 20 pack year smoking has been shown to improve survival. COPD is highly prevalent within LCS programs, with estimated rates of obstructive lung function of up to 59% and evidence of emphysema on CT scan in around 70%.
CONDITIONS
Official Title
Temple Health Chest Initiative (THCI 2.0)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 50 and 80 years old
- Undergoing low dose CT imaging screening for early lung cancer
You will not qualify if you...
- Under 50 years old or over 80 years old
- Not receiving lung cancer screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Temple University Of the Commonwealth System of Higher Education
Philadelphia, Pennsylvania, United States, 19140
Actively Recruiting
Research Team
L
Lauren Miller, BS
CONTACT
S
Stephanie Yerkes, BA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here